Telix Pharmaceuticals Limited (TLX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript — Neutral
TLPPF TLX Seeking Alpha — January 12, 2026Telix Pharmaceuticals Limited (TLX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Simon Property Group: Not The Fattest Yield But One Of The Most Attractive — Positive
SPG Seeking Alpha — January 12, 2026Simon Property Group is paying out a healthy 4.80% dividend yield that's 144% covered by the midpoint of its 2025 FFO guidance range. The REIT continued to expand its portfolio of Class A retail locations with the acquisition of Phillips Place in Charlotte, North Carolina, after acquiring the remaining 12% stake in Taubman. While the preferreds have underperformed on the back of elevated long-term Treasury yields, their current yield at 7.84% offers a healthy level of income.
Why oil prices are shrugging off geopolitical risks in Iran and Venezuela — Neutral
BNO DBO GUSH IEO OIH OIL PXJ UCO USO XOP Yahoo Finance — January 12, 2026Hennessy Energy Transition Fund portfolio manager, Ben Cook, joins Market Catalysts host Julie Hyman to explain oil's (CL=F, BZ=F) price action amid various geopolitical tensions. To watch more expert insights and analysis on the latest market action, check out more Market Catalysts here: https://finance.yahoo.com/videos/series/market-catalysts/ #youtube #oil #Iran #Venezuela #investing About Yahoo Finance: Yahoo Finance provides free stock ticker data, up-to-date news, portfolio management resources, comprehensive market data, advanced tools, and more information to help you manage your financial life.
EPAM Systems: Bullish About Financial Improvement Potential — Positive
EPAM Seeking Alpha — January 12, 2026I continue to assign a "Buy" rating to EPAM Systems, after assessing the factors driving its FY2026 results. EPAM's strategic partnerships and market share gains are supportive of a potential revenue growth acceleration this year. Its operating margins are expected to widen on the back of cost optimization and a shift to higher-value work.
Pfizer Inc. (PFE) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript — Neutral
PFE Seeking Alpha — January 12, 2026Pfizer Inc. (PFE) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Alphabet: Reviewing My 2025 Top Pick, Downgrade To Buy On Less Attractive Setup — Neutral
GOOG GOOGL Seeking Alpha — January 12, 2026Alphabet delivered a 66% return in 2025, outperforming all Magnificent-7 peers and driving S&P 500 gains. I downgrade GOOG from strong buy to buy, citing stretched valuation—forward P/E expanded from 20x to 30x, limiting upside potential. Gemini 3.0's technical superiority and TPUs' strategic value reinforce GOOG's innovation edge, yet major positive catalysts seem priced in.
Balance Portfolios by Pairing ETFs: How Short-Term Bond ETF FLTB Can Help — Positive
FIGB FLTB FSYD ETF Trends — January 12, 2026The ETF wrapper has helped investors craft even more customized portfolios to meet their goals. With its transparency, flexibility, and tax efficiency, the wrapper has empowered asset managers to build increasingly discreetly packaged strategies that serve as building blocks.
China Underrated? Get China Equities in Emerging Markets ETF GEM — Neutral
GEM ETF Trends — January 12, 2026China equities have had their highs and lows in recent years. Having historically provided high levels of growth, debt and governance concerns saw many investors turn from them.
New Year, New Strategy: Navigating Weight Loss ETFs — Positive
HRTS OZEM THNR ETF Trends — January 12, 2026With the start of 2026, the annual focus on weight loss resolutions presents a timely opportunity for financial advisors to discuss the investment potential of GLP-1 agonists with their clients. This class of drugs has fundamentally altered the healthcare sector's growth projections.
KRYS Reports Preliminary Results for 2025, Outlines 2026 Objectives — Neutral
KRYS Zacks Investment Research — January 12, 2026On a preliminary unaudited basis, Krystal Biotech expects revenues of $388-$389M in 2025. The company ended the year with $955M cash, and outlined 2026 plans as its pipeline advances.
Tyson Foods: Protein Powerhouse Set To Benefit From The New Food‑Pyramid Shift — Positive
TSN Seeking Alpha — January 12, 2026Tyson Foods, Inc. is the largest U.S. meat processor, benefiting from a national shift toward protein-rich diets and updated government nutrition guidelines. TSN's chicken segment has returned to profitability, offsetting ongoing beef division losses, with overall financial performance steadily improving post-2023 challenges. Fiscal 2025 saw adjusted EPS up 33% to $4.12, with total sales rising 2.1% or 3.3% adjusted to $54.4 billion despite beef headwinds and modest free cash flow.
Defense Stocks Surge As The U.S. Reasserts Power In Latin America — Positive
CVX Forbes — January 12, 2026What happened in Venezuela on January 3 may turn out to be the most consequential energy and geopolitical event of the decade.
Apple Teams Up With Google for A.I. in Its Products — Positive
AAPL GOOG GOOGL NYTimes — January 12, 2026Apple was facing increasing questions about its plans for artificial intelligence as other big tech companies invested tens of billions in the technology.
Is the Options Market Predicting a Spike in Evergy Stock? — Neutral
EVRG Zacks Investment Research — January 12, 2026Investors need to pay close attention to EVRG stock based on the movements in the options market lately.
Stellantis Pivots From PHEVs to Hybrids and EREVs in North America — Neutral
STLA Zacks Investment Research — January 12, 2026Stellantis scraps U.S. PHEV sales, dropping Jeep and Chrysler plug-ins to refocus on hybrids and EREVs.
The 3 Best Agentic AI Stocks To Buy In 2026 — Positive
AMZN NOW PLTR 24/7 Wall Street — January 12, 2026Agentic AI can change how companies perform operations and how individuals access information.
Securities Fraud Investigation Into Ardent Health, Inc. (ARDT) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm — Neutral
ARDT Business Wire — January 12, 2026LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Ardent Health, Inc. (“Ardent” or the “Company”) (NYSE: ARDT) investors concerning the Company's possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON ARDENT HEALTH, INC. (ARDT), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. What Happened? On Novembe.
General Dynamics to Webcast 2025 Fourth-Quarter and Full-Year Financial Results Conference Call — Neutral
GD PRNewsWire — January 12, 2026RESTON, Va., Jan. 12, 2026 /PRNewswire/ -- General Dynamics (NYSE: GD) will webcast its fourth-quarter and full-year financial results conference call on Wednesday, January 28, beginning at 9 a.m.
Ardent Health (ARDT) Hit With Securities Class Action Amid Receivables and Reserves Issues Driving 33% Plunge – Hagens Berman — Neutral
ARDT GlobeNewsWire — January 12, 2026SAN FRANCISCO, Jan. 12, 2026 (GLOBE NEWSWIRE) -- A securities class action lawsuit has been filed against Ardent Health, Inc. (NYSE: ARDT) following the company's Q3 2025 financial disclosures that revealed significant adverse accounting adjustments totaling about $90 million and sent the stock tumbling over 33% in mid-November. The lawsuit seeks to represent investors who purchased or otherwise acquired Ardent securities between July 18, 2024 and November 12, 2025.
Fermi Inc. (FRMI) Slapped With Securities Class Action Over IPO And Subsequent Disclosures -- Hagens Berman — Neutral
FRMI GlobeNewsWire — January 12, 2026SAN FRANCISCO, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Hyperscaler development company Fermi Inc. (NASDAQ: FRMI) is facing a proposed securities class action stemming from its highly anticipated initial public offering completed just weeks before stunning the investment community with its December announcement that the prospective anchor tenant (“First Tenant”) for the company's Project Matador (the company's Advanced Energy and Intelligence Campus at Texas Tech University) terminated an agreement that would have advanced $150 million to help fund construction. Hagens Berman is investigating the alleged claims that Fermi IPO materials were misleading and urges investors in Fermi who suffered significant losses …